PL1982708T3 - Środek terapeutyczny w przypadku nieswoistego zapalenia jelit zawierający pochodną 2-amino-1.3-propanodiolu jako substancję czynną oraz sposób leczenia nieswoistego zapalenia jelit - Google Patents
Środek terapeutyczny w przypadku nieswoistego zapalenia jelit zawierający pochodną 2-amino-1.3-propanodiolu jako substancję czynną oraz sposób leczenia nieswoistego zapalenia jelitInfo
- Publication number
- PL1982708T3 PL1982708T3 PL07713815T PL07713815T PL1982708T3 PL 1982708 T3 PL1982708 T3 PL 1982708T3 PL 07713815 T PL07713815 T PL 07713815T PL 07713815 T PL07713815 T PL 07713815T PL 1982708 T3 PL1982708 T3 PL 1982708T3
- Authority
- PL
- Poland
- Prior art keywords
- inflammatory bowel
- bowel disease
- propanaediol
- derivative
- amino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006027883 | 2006-02-06 | ||
EP07713815.4A EP1982708B1 (en) | 2006-02-06 | 2007-02-05 | Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease |
PCT/JP2007/051887 WO2007091501A1 (ja) | 2006-02-06 | 2007-02-05 | 2-アミノ-1,3-プロパンジオール誘導体を有効成分とする炎症性腸疾患治療剤又は炎症性腸疾患の治療方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1982708T3 true PL1982708T3 (pl) | 2015-03-31 |
Family
ID=38345101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07713815T PL1982708T3 (pl) | 2006-02-06 | 2007-02-05 | Środek terapeutyczny w przypadku nieswoistego zapalenia jelit zawierający pochodną 2-amino-1.3-propanodiolu jako substancję czynną oraz sposób leczenia nieswoistego zapalenia jelit |
Country Status (30)
Country | Link |
---|---|
US (1) | US8318811B2 (pl) |
EP (2) | EP2520291A1 (pl) |
JP (1) | JP5042042B2 (pl) |
KR (1) | KR101334153B1 (pl) |
CN (1) | CN101378743B (pl) |
AU (1) | AU2007213194B9 (pl) |
BR (1) | BRPI0706971A2 (pl) |
CA (1) | CA2641546C (pl) |
CY (1) | CY1116112T1 (pl) |
DK (1) | DK1982708T3 (pl) |
EC (1) | ECSP088662A (pl) |
ES (1) | ES2524056T3 (pl) |
GT (1) | GT200800148A (pl) |
HK (1) | HK1126119A1 (pl) |
HR (1) | HRP20080421B1 (pl) |
IL (1) | IL192150A (pl) |
MA (1) | MA31338B1 (pl) |
MX (1) | MX2008008872A (pl) |
MY (1) | MY151193A (pl) |
NO (1) | NO20082708L (pl) |
NZ (1) | NZ568907A (pl) |
PL (1) | PL1982708T3 (pl) |
PT (1) | PT1982708E (pl) |
RU (1) | RU2428976C2 (pl) |
SG (1) | SG169370A1 (pl) |
SI (1) | SI1982708T1 (pl) |
TN (1) | TNSN08246A1 (pl) |
TW (1) | TWI389683B (pl) |
WO (1) | WO2007091501A1 (pl) |
ZA (1) | ZA200806199B (pl) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101178318B1 (ko) | 2004-07-16 | 2012-08-29 | 교린 세이야꾸 가부시키 가이샤 | 효과적인 의약의 사용법 및 부작용 발현의 방어에 관한방법 |
EP1806338B1 (en) | 2004-10-12 | 2016-01-20 | Kyorin Pharmaceutical Co., Ltd. | Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof |
AU2006300485B2 (en) | 2005-10-07 | 2011-08-25 | Kyorin Pharmaceutical Co., Ltd. | Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
TWI389683B (zh) | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
US8232319B2 (en) | 2006-08-08 | 2012-07-31 | Kyorin Pharmaceutical Co., Ltd. | Amino phosphate derivative and S1P receptor modulator having same as an active ingredient |
NZ574012A (en) | 2006-08-08 | 2012-02-24 | Kyorin Seiyaku Kk | Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
WO2009099174A1 (ja) * | 2008-02-07 | 2009-08-13 | Kyorin Pharmaceutical Co., Ltd. | アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤 |
JPWO2009142195A1 (ja) * | 2008-05-20 | 2011-09-29 | 杏林製薬株式会社 | 寛解導入維持剤 |
KR20180023049A (ko) | 2008-07-23 | 2018-03-06 | 아레나 파마슈티칼스, 인크. | 자가면역성 및 염증성의 장애의 치료에 유용한 치환된 1,2,3,4-테트라히드로시클로펜타[b]인돌-3-일)아세트산 유도체 |
EP2342205B1 (en) | 2008-08-27 | 2016-04-20 | Arena Pharmaceuticals, Inc. | Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
EP2177521A1 (en) | 2008-10-14 | 2010-04-21 | Almirall, S.A. | New 2-Amidothiadiazole Derivatives |
US8269043B2 (en) * | 2008-10-30 | 2012-09-18 | Biogen Idec Ma Inc. | Bicyclic aryl sphingosine 1-phosphate analogs |
EP2202232A1 (en) | 2008-12-26 | 2010-06-30 | Laboratorios Almirall, S.A. | 1,2,4-oxadiazole derivatives and their therapeutic use |
EP2210890A1 (en) | 2009-01-19 | 2010-07-28 | Almirall, S.A. | Oxadiazole derivatives as S1P1 receptor agonists |
EP2305660A1 (en) | 2009-09-25 | 2011-04-06 | Almirall, S.A. | New thiadiazole derivatives |
EP2343287A1 (en) | 2009-12-10 | 2011-07-13 | Almirall, S.A. | New 2-aminothiadiazole derivatives |
EP4148045A1 (en) | 2010-01-27 | 2023-03-15 | Arena Pharmaceuticals, Inc. | Intermediate compounds for the preparation of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b] indol-3-yl)acetic acid and salts thereof |
SG10201501575VA (en) | 2010-03-03 | 2015-04-29 | Arena Pharm Inc | Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
EP2366702A1 (en) | 2010-03-18 | 2011-09-21 | Almirall, S.A. | New oxadiazole derivatives |
EP2390252A1 (en) | 2010-05-19 | 2011-11-30 | Almirall, S.A. | New pyrazole derivatives |
EP2455081A1 (en) * | 2010-11-23 | 2012-05-23 | Almirall, S.A. | S1P1 receptor agonists for use in the treatment of crohn's disease |
JO3177B1 (ar) | 2011-04-01 | 2018-03-08 | Novartis Ag | تركيبات تتالف من 2-أمينو-2- [ 2- ( 4- أكتيل فينيل ) إثيل ] بروبان - 3, 1- ديول |
KR101787543B1 (ko) | 2014-08-22 | 2017-10-19 | 샘표식품 주식회사 | 발효배양 산삼을 포함하는 항염증 조성물 |
JP6895378B2 (ja) | 2015-01-06 | 2021-06-30 | アリーナ ファーマシューティカルズ, インコーポレイテッド | S1p1受容体に関連する状態の処置方法 |
EP3939965A1 (en) | 2015-06-22 | 2022-01-19 | Arena Pharmaceuticals, Inc. | Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in sipi receptor-associated disorders |
CN110520124A (zh) | 2017-02-16 | 2019-11-29 | 艾尼纳制药公司 | 用于治疗原发性胆汁性胆管炎的化合物和方法 |
WO2018151834A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations |
JP7389486B2 (ja) | 2018-07-27 | 2023-11-30 | プリオセラ リミテッド | 造血幹細胞移植を受けた患者における血液悪性腫瘍の再発抑制剤 |
KR20210074291A (ko) | 2018-09-06 | 2021-06-21 | 아레나 파마슈티칼스, 인크. | 자가면역 및 염증성 장애의 치료에 유용한 화합물 |
Family Cites Families (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2579602B2 (ja) * | 1992-10-21 | 1997-02-05 | 吉富製薬株式会社 | 2−アミノ−1,3−プロパンジオール化合物および免疫抑制剤 |
US5948820A (en) * | 1994-08-22 | 1999-09-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzene compound and pharmaceutical use thereof |
US5447922A (en) * | 1994-08-24 | 1995-09-05 | Bristol-Myers Squibb Company | α-phosphonosulfinic squalene synthetase inhibitors |
IL155066A (en) * | 1997-04-04 | 2004-06-20 | Mitsubishi Pharma Corp | History 2 - Amino - 2 - (2 - Ethyl (converted)) Propane - 1, 3 - Diol Efficacy in the preparation of 2 - Aminopropene - 1, 3 - Diol |
JPH1180026A (ja) * | 1997-09-02 | 1999-03-23 | Yoshitomi Pharmaceut Ind Ltd | 新規免疫抑制剤、その使用方法およびその同定方法 |
DE69935718T2 (de) * | 1998-07-02 | 2007-12-27 | Kyowa Hakko Kogyo Co., Ltd. | Antidiabetische medikamente |
AU767241B2 (en) * | 1998-09-14 | 2003-11-06 | Qiang Xu | Immunosuppressive agents |
US20020143034A1 (en) * | 1998-12-30 | 2002-10-03 | Fujisawa Pharmaceutical Co. Ltd. | Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
AU2001264313A1 (en) | 2000-06-20 | 2002-01-02 | Japan Tobacco Inc. | Pyrazolopyridine compounds and use thereof as drugs |
CN1267429C (zh) * | 2000-07-13 | 2006-08-02 | 三共株式会社 | 氨基醇衍生物 |
JP2002053575A (ja) | 2000-08-09 | 2002-02-19 | Sankyo Co Ltd | アミノアルコ−ル類 |
JP2004507552A (ja) * | 2000-08-31 | 2004-03-11 | メルク エンド カムパニー インコーポレーテッド | 免疫調節剤としてのリン酸誘導体 |
EP1383778B1 (en) * | 2001-01-30 | 2009-10-21 | University Of Virginia Patent Foundation | Agonists and antagonists of sphingosine-1-phosphate receptors |
ATE447970T1 (de) * | 2001-02-08 | 2009-11-15 | Ono Pharmaceutical Co | Mittel zur behandlung von harnwegserkrankungen, umfassend mittel zur kontrolle des lpa-rezeptors |
JP4318921B2 (ja) * | 2001-02-22 | 2009-08-26 | ノバルティス アクチエンゲゼルシャフト | 移植片の機能発現遅延の処置のための医薬の製造のためのリンパ球ホーミング促進剤の使用 |
ATE314383T1 (de) * | 2001-03-26 | 2006-01-15 | Novartis Pharma Gmbh | 2-amino-propanol derivate |
JP2002316985A (ja) | 2001-04-20 | 2002-10-31 | Sankyo Co Ltd | ベンゾチオフェン誘導体 |
WO2002092068A1 (fr) * | 2001-05-10 | 2002-11-21 | Ono Pharmaceutical Co., Ltd. | Derives d'acide carboxylique et medicaments contenant ces derives comme principe actif |
JP2004534772A (ja) * | 2001-05-24 | 2004-11-18 | 藤沢薬品工業株式会社 | アミノアルコール誘導体 |
EP1424078A4 (en) * | 2001-09-04 | 2009-03-25 | Ono Pharmaceutical Co | RESPIRATORY DISEASE MEDICINES COMPRISING A SPHINGOSINE-1-PHOSPHATE RECEPTOR REGULATING AGENT |
WO2003029184A1 (fr) | 2001-09-27 | 2003-04-10 | Kyorin Pharmaceutical Co., Ltd. | Derive d'ether de diaryle, son sel d'addition et son immunosuppresseur |
US6960692B2 (en) | 2001-09-27 | 2005-11-01 | Kyorin Pharmaceutical Co., Ltd. | Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
JP4035759B2 (ja) | 2001-11-06 | 2008-01-23 | 独立行政法人産業技術総合研究所 | アミノアルコールリン酸化合物、製造方法、及びその利用方法 |
JP2003267936A (ja) | 2002-01-11 | 2003-09-25 | Sankyo Co Ltd | ベンゼン環化合物 |
ATE435202T1 (de) * | 2002-01-11 | 2009-07-15 | Daiichi Sankyo Co Ltd | Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung |
CA2472715A1 (en) * | 2002-01-18 | 2003-07-31 | Merck & Co., Inc. | Edg receptor agonists |
US20040058894A1 (en) * | 2002-01-18 | 2004-03-25 | Doherty George A. | Selective S1P1/Edg1 receptor agonists |
ATE448193T1 (de) * | 2002-01-18 | 2009-11-15 | Merck & Co Inc | ßN-(BENZYL)AMINOALKYL CARBOXYLATE, PHOSPHINATE, PHOSPHONATE UND TETRAZOLE ALS EDG REZEPTORAGONISTENß |
AU2003217764A1 (en) * | 2002-03-01 | 2003-09-16 | Merck & Co., Inc. | Aminoalkylphosphonates and related compounds as edg receptor agonists |
EP1482896A4 (en) * | 2002-03-01 | 2005-11-23 | Merck & Co Inc | AMINOALKYLPHOSPHONATES AND ASSOCIATED COMPOUNDS AS EDG RECEPTOR AGONISTS |
EP1549640A4 (en) * | 2002-06-17 | 2008-08-06 | Merck & Co Inc | 1 - ((5-ARYL-1,2,4-OXADIAZOL-3-YL) BENZYL) AZETIDINE-3-CARBOXYLATE AND 1 - ((5-ARYL-1,2,4-OXADIAZOL-3-YL) BENZYL) PYRROLIDIN-3-CARBOXYLATE AS EDG RECEPTOR AGONISTS |
JPWO2004002531A1 (ja) * | 2002-06-26 | 2005-10-27 | 小野薬品工業株式会社 | 血管の収縮または拡張による疾患治療剤 |
EP1546110A4 (en) * | 2002-07-30 | 2008-03-26 | Univ Virginia | ACTIVE COMPOUNDS IN THE SIGNALING OF SPHINGOSINE 1-PHOSPHATE |
JP4166218B2 (ja) * | 2002-09-13 | 2008-10-15 | ノバルティス アクチエンゲゼルシャフト | アミノ−プロパノール誘導体 |
BR0314455A (pt) * | 2002-09-19 | 2005-07-26 | Kyorin Seiyaku Kk | Derivados de aminoálcool, seus sais e agentes imunosupressores |
KR20050054958A (ko) * | 2002-09-24 | 2005-06-10 | 노파르티스 아게 | 탈수초성 장애의 치료에 있어서의 스핑고신-1-포스페이트수용체 아고니스트 |
TW200408393A (en) * | 2002-10-03 | 2004-06-01 | Ono Pharmaceutical Co | Antagonist of lysophosphatidine acid receptor |
JP4140698B2 (ja) | 2002-10-18 | 2008-08-27 | 第一三共株式会社 | リン酸又はホスホン酸誘導体 |
US7220734B2 (en) * | 2002-12-20 | 2007-05-22 | Merck & Co., Inc. | 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists |
EP1594508B1 (en) * | 2003-02-11 | 2012-08-08 | Irm Llc | Novel bicyclic compounds and compositions |
CN100344638C (zh) * | 2003-02-18 | 2007-10-24 | 杏林制药株式会社 | 氨基膦酸衍生物、其加成盐以及s1p受体调节剂 |
KR20050121712A (ko) * | 2003-04-08 | 2005-12-27 | 노파르티스 아게 | 유기 화합물 |
JP2004307442A (ja) | 2003-04-10 | 2004-11-04 | Kyorin Pharmaceut Co Ltd | ヘテロ環誘導体とその付加塩及び免疫抑制剤 |
JP2004307440A (ja) | 2003-04-10 | 2004-11-04 | Kyorin Pharmaceut Co Ltd | 2−アミノ‐1,3‐プロパンジオール誘導体とその付加塩 |
JP2004307441A (ja) | 2003-04-10 | 2004-11-04 | Kyorin Pharmaceut Co Ltd | ベンゼン誘導体とその付加塩及び免疫抑制剤 |
JP2004307439A (ja) | 2003-04-10 | 2004-11-04 | Kyorin Pharmaceut Co Ltd | アミノジオール誘導体とその付加塩及び免疫抑制剤 |
ATE547395T1 (de) * | 2003-04-30 | 2012-03-15 | Novartis Pharma Gmbh | Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors |
US7825260B2 (en) * | 2003-04-30 | 2010-11-02 | Novartis Ag | Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
EP1625123A4 (en) * | 2003-05-15 | 2007-08-29 | Merck & Co Inc | 3- (2-AMINO-1-AZACYCLYL) -5-ARYL-1,2,4-OXADIAZOLE AS S1P RECEPTOR AGONISTS |
SI1638551T1 (sl) * | 2003-05-19 | 2012-04-30 | Irm Llc | Imunosupresivne spojine in sestavki |
GB0313612D0 (en) * | 2003-06-12 | 2003-07-16 | Novartis Ag | Organic compounds |
JP2005047899A (ja) | 2003-07-11 | 2005-02-24 | Sankyo Co Ltd | アミノアルコール化合物 |
TW200505416A (en) | 2003-08-12 | 2005-02-16 | Mitsubishi Pharma Corp | Bi-aryl compound having immunosuppressive activity |
TW200510437A (en) | 2003-08-12 | 2005-03-16 | Mitsubishi Pharma Corp | Phosphinane compound with immunomodulating activity |
CA2535704C (en) * | 2003-08-28 | 2012-12-11 | Novartis Ag | Aminopropanol derivatives |
CN101407471A (zh) * | 2003-08-29 | 2009-04-15 | 小野药品工业株式会社 | 能够结合s1p受体的化合物及其药物用途 |
CA2539438A1 (en) * | 2003-10-01 | 2005-04-14 | Merck And Co., Inc. | 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |
GB0324210D0 (en) * | 2003-10-15 | 2003-11-19 | Novartis Ag | Organic compounds |
WO2005041899A2 (en) * | 2003-11-03 | 2005-05-12 | University Of Virginia Patent Foundation | Orally available sphingosine 1-phosphate receptor agonists and antagonists |
AU2004299456B2 (en) * | 2003-12-17 | 2010-10-07 | Merck Sharp & Dohme Corp. | (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists |
TW200526548A (en) | 2003-12-25 | 2005-08-16 | Sankyo Co | Ether derivatives |
GB0401332D0 (en) * | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
JP4740884B2 (ja) * | 2004-02-24 | 2011-08-03 | アイアールエム・リミテッド・ライアビリティ・カンパニー | 免疫抑制性化合物および組成物 |
JP2005272453A (ja) * | 2004-02-24 | 2005-10-06 | Sankyo Co Ltd | アミノアルコール化合物 |
TW200538433A (en) * | 2004-02-24 | 2005-12-01 | Irm Llc | Immunosuppressant compounds and compositiions |
JP2005247691A (ja) | 2004-03-01 | 2005-09-15 | Toa Eiyo Ltd | S1p3受容体拮抗薬 |
GB0405289D0 (en) * | 2004-03-09 | 2004-04-21 | Novartis Ag | Organic compounds |
EP2272531A3 (en) * | 2004-04-30 | 2011-04-13 | Novartis Vaccines and Diagnostics S.r.l. | Integration of meningococcal conjugate vaccination |
BRPI0510627A (pt) * | 2004-05-03 | 2007-10-30 | Novartis Ag | combinações que compreendem um agonista do receptor s1p e um inibidor da jak3 quinase |
GB0411929D0 (en) * | 2004-05-27 | 2004-06-30 | Novartis Ag | Organic compounds |
US8039674B2 (en) * | 2004-06-23 | 2011-10-18 | Ono Pharmaceutical Co., Ltd. | Compound having S1P receptor binding potency and use thereof |
KR101178318B1 (ko) * | 2004-07-16 | 2012-08-29 | 교린 세이야꾸 가부시키 가이샤 | 효과적인 의약의 사용법 및 부작용 발현의 방어에 관한방법 |
TW200611687A (en) * | 2004-07-29 | 2006-04-16 | Sankyo Co | Pharmaceutical compositions used for immunosuppressant |
KR20070058455A (ko) * | 2004-08-13 | 2007-06-08 | 프래시스 파마슈티컬즈 인코포레이티드 | 스핑고신-1-포스페이트(s1p) 수용체 활성을 조절하기위한 방법 및 조성물 |
WO2006041015A1 (ja) | 2004-10-12 | 2006-04-20 | Kyorin Pharmaceutical Co., Ltd. | アミノアルコール誘導体とその付加塩及び免疫抑制剤 |
EP1806338B1 (en) * | 2004-10-12 | 2016-01-20 | Kyorin Pharmaceutical Co., Ltd. | Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof |
MX2007006706A (es) | 2004-12-06 | 2007-10-18 | Univ Virginia | Analogos de esfingosina 1-fosfato amida de arilo. |
TW200702326A (en) | 2005-05-31 | 2007-01-16 | Mitsubishi Pharma Corp | 2-aminobutanol compound and its pharmaceutical use |
TWI418350B (zh) * | 2005-06-24 | 2013-12-11 | Sankyo Co | 含有ppar調節劑之醫藥組成物的用途 |
RU2493840C2 (ru) * | 2005-09-09 | 2013-09-27 | Новартис Аг | Лечение аутоиммунных заболеваний |
AU2006300485B2 (en) | 2005-10-07 | 2011-08-25 | Kyorin Pharmaceutical Co., Ltd. | Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
CA2626011A1 (en) | 2005-10-12 | 2007-04-19 | Toa Eiyo Ltd. | S1p3 receptor antagonist |
TWI389683B (zh) | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
AU2007279311A1 (en) * | 2006-07-25 | 2008-01-31 | Alcon Research, Ltd. | Antagonists of endothelial differentiation gene subfamily 3 (Edg-3, S1P3) receptors for prevention and treatment of ocular disorders |
US7877152B2 (en) * | 2006-07-31 | 2011-01-25 | JusJas LLC | Bipolar stimulation/recording device with widely spaced electrodes |
-
2007
- 2007-01-25 TW TW096102882A patent/TWI389683B/zh not_active IP Right Cessation
- 2007-02-05 PT PT77138154T patent/PT1982708E/pt unknown
- 2007-02-05 RU RU2008135264/15A patent/RU2428976C2/ru not_active IP Right Cessation
- 2007-02-05 NZ NZ568907A patent/NZ568907A/en not_active IP Right Cessation
- 2007-02-05 AU AU2007213194A patent/AU2007213194B9/en not_active Ceased
- 2007-02-05 PL PL07713815T patent/PL1982708T3/pl unknown
- 2007-02-05 SI SI200731574T patent/SI1982708T1/sl unknown
- 2007-02-05 SG SG201100761-4A patent/SG169370A1/en unknown
- 2007-02-05 MY MYPI20082159 patent/MY151193A/en unknown
- 2007-02-05 BR BRPI0706971-5A patent/BRPI0706971A2/pt not_active IP Right Cessation
- 2007-02-05 KR KR1020087017968A patent/KR101334153B1/ko not_active IP Right Cessation
- 2007-02-05 CA CA2641546A patent/CA2641546C/en not_active Expired - Fee Related
- 2007-02-05 CN CN200780004468.6A patent/CN101378743B/zh not_active Expired - Fee Related
- 2007-02-05 MX MX2008008872A patent/MX2008008872A/es active IP Right Grant
- 2007-02-05 EP EP12167430A patent/EP2520291A1/en not_active Withdrawn
- 2007-02-05 ES ES07713815.4T patent/ES2524056T3/es active Active
- 2007-02-05 WO PCT/JP2007/051887 patent/WO2007091501A1/ja active Application Filing
- 2007-02-05 EP EP07713815.4A patent/EP1982708B1/en active Active
- 2007-02-05 DK DK07713815.4T patent/DK1982708T3/en active
- 2007-02-05 US US12/223,584 patent/US8318811B2/en active Active
- 2007-02-05 JP JP2007557819A patent/JP5042042B2/ja not_active Expired - Fee Related
-
2008
- 2008-06-06 TN TNP2008000246A patent/TNSN08246A1/en unknown
- 2008-06-12 IL IL192150A patent/IL192150A/en not_active IP Right Cessation
- 2008-06-12 NO NO20082708A patent/NO20082708L/no not_active Application Discontinuation
- 2008-07-16 ZA ZA200806199A patent/ZA200806199B/xx unknown
- 2008-07-25 GT GT200800148A patent/GT200800148A/es unknown
- 2008-08-05 EC EC2008008662A patent/ECSP088662A/es unknown
- 2008-08-26 MA MA31196A patent/MA31338B1/fr unknown
- 2008-08-28 HR HRP20080421AA patent/HRP20080421B1/hr not_active IP Right Cessation
-
2009
- 2009-05-14 HK HK09104420A patent/HK1126119A1/xx not_active IP Right Cessation
-
2015
- 2015-01-26 CY CY20151100081T patent/CY1116112T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200806199B (en) | Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease | |
IL209282A (en) | History of n-pipridine-3-yl-2-benzimidazole carboxamide and drugs containing it for the treatment of cardiovascular disease | |
EP1804813A4 (en) | FORMULATIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
PL2371853T3 (pl) | Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, kompozycja farmaceutyczna, zastosowanie pochodnej insuliny lub jej farmaceutycznie dopuszczalnej soli oraz sposób leczenia | |
IL176960A0 (en) | Compositions and methods of treatment for inflammatory diseases | |
EP1920770A4 (en) | THERAPEUTIC AGENT AGAINST INFLAMMATORY DISEASE AND TNF ALPHA PRODUCTION DISEASE | |
HK1126427A1 (zh) | 用於治療與血管通透性相關的疾病的低劑量雷帕霉素 | |
EP1932522A4 (en) | THERAPEUTIC AGENT FOR LIVER DISEASE CONTAINING 2-AMINO-1,3-PROPANEDIOL DERIVATIVE AS AN ACTIVE INGREDIENT AND ASSOCIATED THERAPEUTIC METHOD FOR LIVER DISEASE | |
IL197934A (en) | History of hydrobenzamide as hsp90 inhibitors and their use in the treatment of disease | |
IL201189A (en) | Fluorization derivatifrone derivatives used as iron pellets in the treatment of neurodegenerative diseases, their preparation and their pharmaceutical preparations | |
IL196202A0 (en) | Indazole derivatives for the treatment of hsp90-induced diseases | |
PT1828151E (pt) | Derivados de malonamida como inibidores de gama-secretase para o tratamento da doença de alzheimer | |
EP2142549A4 (en) | ADENOSINE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES THEREOF CONTAINING THEM AS AN ACTIVE SUBSTANCE | |
HK1141708A1 (en) | Agent for treatment of pulmonary disease | |
EP1915998A4 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR CORNEAL OR CONJUNCTIVAL DISEASE | |
IL201418A0 (en) | Therapeutic agent for glaucoma containing adenosine derivative as active ingredient | |
EP2099446A4 (en) | METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASE | |
EP1948210A4 (en) | METHOD FOR TREATING ISCHEMIC HEART DISEASE | |
EP2098228A4 (en) | ANTI-INFLAMMATORY AGENT CONTAINING 2-AMINOPHENOL OR A DERIVATIVE THEREOF AS ACTIVE INGREDIENT | |
EP1827459A4 (en) | THERAPEUTIC COMPOSITION COMPRISING ANTISENSE OLIGONUCLEOTIDE FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASES | |
IL194066A0 (en) | Therapeutic composition for treatment of tinnitus | |
EP2077847A4 (en) | DI- AND ALKYL AND HALOGENATED TRISACCHARIDES AND PHARMACEUTICAL PREPARATIONS, DIAGNOSTIC KITS AND METHODS FOR TREATMENT THEREOF | |
ZA200704684B (en) | Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease | |
EP1967208A4 (en) | THERAPEUTIC AGENT FOR SKIN OR AGENT PROMOTING REGENERATION OF SKIN CONTAINING GHRELINE, AND DERIVATIVES THEREOF OR SUBSTANCE CAPABLE OF ACTING AS ACTIVE INGREDIENT ON GHS-R1a | |
EP1967201A4 (en) | THERAPEUTIC AGENT FOR SKIN OR SKIN REGENERATING AGENT CONTAINING DESACYL-GHRELINE OR A DERIVATIVE THEREOF AS ACTIVE INGREDIENT |